|
|
| Research article summary (published Oct 2006): |
Prognostic value of humbug gene overexpression in stage II colon cancer.
Full Abstract
Overexpression of aspartyl (asparaginyl) beta-hydroxylase (AAH) has been demonstrated in hepatocellular carcinoma, cholangiocarcinoma, and pancreatic carcinoma. AAH has an important role in regulating cell motility and invasiveness. Humbug is a truncated homolog of AAH, with a role in calcium regulation. The present study examines the prognostic use of AAH and humbug gene expression in stage II colon cancer. One hundred thirty cases of TNM stage II colon carcinoma were retrieved from the Rhode Island Hospital pathology archives. Tissue microarrays were immunostained with the FB50 and 15C7 monoclonal antibodies generated to recombinant AAH. However, FB50 also recognizes humbug. In addition, AAH and humbug expression was analyzed in samples of colon cancer and adjacent normal mucosa by real-time quantitative reverse transcriptase-polymerase chain reaction. Humbug (FB50) expression was localized to the tumor cytoplasm, whereas normal colonic epithelium did not exhibit significant immunoreactivity. Humbug staining was detected in 85% of the neoplasms, 23% of which stained strongly. Strong humbug immunoreactivity positively correlated with nuclear grade (P = .006) and inversely with survival (P = .027). In contrast to humbug, AAH (15C7) immunoreactivity was seen in normal and neoplastic epithelium. There was no correlation between AAH immunoreactivity and tumor grade, or survival. Correspondingly, reverse transcriptase-polymerase chain reaction studies demonstrated up-regulation of humbug but not AAH in 95% of colon carcinomas relative to adjacent colon cancer-free mucosa (P < .0001). This study demonstrates that high levels of humbug immunoreactivity in colon carcinomas correlate with histologic grade and tumor behavior, suggesting that humbug can serve as a prognostic biomarker of TNM stage II colon cancers. In addition, molecular studies demonstrated that the increased levels of FB50 detected were due to humbug, as opposed to AAH overexpression.
Learn Faster Today Improve your study skills
Author information
Author/s: Wang, JiYi (J); de la Monte, Suzanne M (SM); Sabo, Edmond (E); Kethu, Sripathi (S); Tavares, Rosemarie (R); Branda, Mark (M); Simao, Lelia (L); Wands, Jack R (JR); Resnick, Murray B (MB);
Affiliation: Department of Pathology, Liver Research Center, Rhode Island Hospital, Brown Medical School, Providence, RI 02903, USA.
Grants: 5 P20 RR017695-02 (Agency:NCRR NIH HHS) ; AA-02169 (Agency:NIAAA NIH HHS) ; AA-02666 (Agency:NIAAA NIH HHS) ; AA-11431 (Agency:NIAAA NIH HHS) ; AA-12908 (Agency:NIAAA NIH HHS) ; CA-35711 (Agency:NCI NIH HHS)
Journal and publication information
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal: Human pathology (Hum Pathol), published in United States. (Language: eng)
Reference: 2007-Jan; vol 38 (issue 1) : pp 17-25
Dates: Created 2006/12/15; Completed 2007/02/15; Revised 2007/12/03;
PMID: 17020779, status: MEDLINE (last retrieval date: 12/26/2008)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article (including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
|
|
Related articles
These are the highest related articles currently in the database:
- Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression after administration of 5-fluorouracil to patients with colorectal cancer.
13 Jun 2007 - Colorectal cancer or colon and rectal cancer? Clinicopathological comparison between colonic and rectal carcinomas.
9 Mar 2008 - Lysyl oxidase-like 2 expression is increased in colon and esophageal tumors and associated with less differentiated colon tumors.
29 Jun 2007 - Isoform-specific up-regulation of plasma membrane Ca2+ATPase expression during colon and gastric cancer cell differentiation.
9 Apr 2007 - Tumour location is a prognostic factor for survival in colonic cancer patients.
31 Jul 2007 - Adjuvant therapy for colon cancer.
29 Sep 2007 - MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma.
28 Jan 2008 - Prognostic significance of defective mismatch repair and BRAF V600E in patients with colon cancer.
30 May 2008 - Development of a clinically feasible molecular assay to predict recurrence of stage II colon cancer.
11 Jun 2008 - Expression of peroxisome proliferator-activated receptor-gamma in colon cancer: correlation with histopathological parameters, cell cycle-related molecules, and patients' survival.
26 Mar 2007
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.